Nkemdirim Okere Arinze, Sanogo Vassiki, Balkrishnan Rajesh, Diaby Vakaramoko
College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, 1415 Martin Luther King Jr. BLVD, Tallahassee, FL 32307, USA.
Department of Pharmaceutical outcomes and Policy, College of Pharmacy, University of Florida, USA.
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105053. doi: 10.1016/j.jstrokecerebrovasdis.2020.105053. Epub 2020 Jun 25.
Continuity of care is a core element of high-quality patient care in a primary care setting and one of a national priority.
To assess and quantify the impact of continuity of care on 30-day readmissions, 30-day inpatient mortality, and hospital length of stay (LOS), among hospitalized patients with acute ischemic stroke disease.
Observational retrospective cohort (n = 356,134) using a 2.75% random sample (n=1,036,753) from the State of Florida Agency for Health Care Administration (AHCA) database from 2006 to 2016.
We assessed continuity of care using an integrated continuity of care CoC score, calculated by merging three standard indices of continuity of care - Bice-Boxerman Continuity of Care Index (COCI), Herfindahl Index (HI), and Usual Provider of Care (UPC) Index via a Principal Component Analysis (PCA). We measured 30-day hospital readmissions, 30-day inpatient mortality, and LOS.
Our analysis revealed that hospital LOS was significantly affected by CoC. The statistically significant average treatment effect (ATEs), expressed in risk difference (RD), ranged between 0.27 [95%CI: (0.07, 0.48)] and 1.0 day [95%CI: (0.57, 1.43)]. A similar trend was observed for 30-day readmission (ATEs ranging from 0.0067 [95%CI: (0.0002, 0.0132) to 0.0071 [95%CI: (0.0005, 0.0136)]), and inpatient mortality (ATEs ranging from 0.0006 [95% confidence interval (CI): (0.0001, 0.0012)] to 0.0007 [95%CI: (0.0001, 0.0012)]).
Our findings suggest a strong association between continuity of care and clinical outcomes. Continuity of care leads to a reduction in mortality, rehospitalization, and hospital length of stay.
连续性医疗是基层医疗环境中高质量患者护理的核心要素,也是国家优先事项之一。
评估并量化连续性医疗对急性缺血性中风疾病住院患者30天再入院率、30天住院死亡率和住院时间(LOS)的影响。
采用观察性回顾性队列研究(n = 356,134),样本来自2006年至2016年佛罗里达州医疗保健管理局(AHCA)数据库中2.75%的随机样本(n = 1,036,753)。
我们使用综合连续性医疗CoC评分评估连续性医疗,该评分通过主成分分析(PCA)合并三个连续性医疗标准指标——比塞 - 博克斯曼连续性医疗指数(COCI)、赫芬达尔指数(HI)和常规护理提供者(UPC)指数来计算。我们测量了30天医院再入院率、30天住院死亡率和住院时间。
我们的分析显示,连续性医疗对住院时间有显著影响。以风险差异(RD)表示的具有统计学意义的平均治疗效果(ATEs)范围在0.27 [95%置信区间(CI):(0.07, 0.48)]至1.0天[95%CI:(0.57, 1.43)]之间。30天再入院率(ATEs范围从0.0067 [95%CI:(0.0002, 0.0132)]至0.0071 [95%CI:(0.0005, 0.0136)])和住院死亡率(ATEs范围从0.0006 [95%置信区间(CI):(0.0001, 0.0012)]至0.0007 [95%CI:(0.0001, 0.0012)])也观察到类似趋势。
我们的研究结果表明连续性医疗与临床结局之间存在密切关联。连续性医疗可降低死亡率、再住院率和住院时间。